Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz

August 30, 2024
Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared HolzUpside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz
Share This

Jared Holz, Mizuho, joins ‘Fast Money’ to talk opportunities in pharma investing following approval of Emergent Bio’s Mpox vaccine.


 

Latest Mizuho News

Mizuho Expands “A Name Worth Knowing Award” to Support Two Promising Junior Golfers

Mizuho Expands “A Name Worth Knowing Award” to Support Two Promising Junior Golfers

May 8, 2026
Head of Investment and Corporate Banking Michal Katz on Bloomberg The Close (Starts at 1:15)

Head of Investment and Corporate Banking Michal Katz on Bloomberg The Close (Starts at 1:15)

April 29, 2026
All eyes on Coinbase after Robinhood's crypto revenue falls 47%

All eyes on Coinbase after Robinhood's crypto revenue falls 47%

May 5, 2026

Mizuho news from around the globe

back-to-top-blue